Scientific Data: In the OASIS 4 trial, 74% of participants experienced at least one gastrointestinal side effect
Cindy Cai, M.D., principal investigator and Jonathan and Marcia Javitt Rising Professor of Ophthalmology at Johns Hopkins Medicine, says the study was designed to resolve existing, conflicting research on the possible link between GLP-1 RAs and age-related macular degeneration
Comparing GLP-1 Weight Loss Medications Potential Side Effects of GLP-1 Medications Common side effects include: Nausea, bloating, or diarrhoea Fatigue or headaches Constipation during dose escalation Rarely: pancreatitis or gallbladder inflammation Most symptoms improve over time
In fact, a survey of GLP-1 users found 27% of the 1,745 participants experienced some changes to their menstrual cycle 3
Key Safety Factors and Baseline Assessment for UC Patients Before starting GLP-1 therapy, patients with ulcerative colitis should have documented disease remission or stable, mild inflammation
The practical PeptideStack default is the same one we use in our broader how long reconstituted peptides last guide: about 28 days at 2-8 C when mixed with bacteriostatic water, handled cleanly, and protected from light